http://finance.yahoo.com/news/china-cord-blood-closes-65m-184906385.htmlNEW YORK (AP) -- China Cord Blood Corp. said Friday that it closed a $65 million convertible debt financing deal with an investment fund managed by Kohlberg Kravis Roberts & Co. KKR partner Julian Wolhardt, who has focused on private equity deals in China, was named to the China Cord board. China Cord collects, tests, processes and stores umbilical cord blood that contains stem cells, which can be used to treat certain diseases. The company announced the KKR deal on April 12. The company said the debt carries a 7 percent annual interest rate and matures in five years, with holders having the right to convert the debt into shares for a conversion price of $2.838. If fully converted, the shares represent 23.8 percent of the company's enlarged share capital. U.S. shares of China Cord rose 4 cents to $2.94 in afternoon trading.
This stock will be over $3 in 5 years.
CBAI sure the he** hasnt done it so who cares?
That's correct ...daniel ..... !